N.M. Code R. § 20.11.69.7 Definitions

• Library: New Mexico Administrative Code
• Edition: 2023
• Currency: Current through Register Vol. 34, No. 24, December 19, 2023
• Citation: N.M. Code R. § 20.11.69.7
• Year: 2023

In addition to the definitions in 20.11.69.7 NMAC the definitions in 20.11.1 NMAC apply unless there is a conflict between definitions, in which case the definition in 20.11.69 NMAC shall govern.

A. "Charging capacity" means the pathological waste destructor manufacturers or designers rated capacity expressed in terms of pounds per hour (lb/hr).

B. "Charging rate" means the actual rate at which the subject unit is burning waste at a given point in time expressed in terms of pounds per hour (lb/hr).

C. "Chemotherapeutic waste" means all wastes resulting from the production or use of anti-neoplastic agents used for the purpose of stopping or reversing the growth of malignant cells. Chemotherapeutic wastes shall not include any waste containing anti-neoplastic agents that are listed as hazardous waste.

D. "Continuous emission monitor" means the total equipment required to sample and analyze emissions or process parameters on a continuous basis.

E. "DSCF" means dry standard cubic foot with standard conditions being a temperature of 68 degrees F and a pressure of 29.92 inches Hg.

F. "DSCM" means dry standard cubic meter with standard conditions being a temperature of 68 degrees F and a pressure of 29.92 inches Hg.

G. "gr" means grains.

H. "Hazardous waste" means hazardous waste as defined in 40 CFR Part 261.3 as amended.

I. "Infectious waste" means a limited class of substances that carry a significant risk of transmitting disease, including but not limited to:

(1) microbiology laboratory wastes, including cultures and stocks of infectious agents from clinical research and industrial laboratories, and disposable culture dishes and devices used to transfer, inoculate and mix cultures;

(2) pathological wastes, including human or animal tissues, organs and body parts, removed during surgery, autopsy or biopsy;

(3) disposable equipment instruments, utensils, and other disposable materials which require special precautions because of contamination by highly contagious diseases;

(4) blood and blood products, including waste blood, blood serum, plasma and blood products;

(5) contaminated sharps, including contaminated hypodermic needles, syringes, scalpel blades, Pasteur pipettes and broken glass; and

(6) contaminated animal carcasses, body parts and bedding, especially those intentionally exposed to...